FDA Clearance Tracker · P950005-S084
CELSIUS
Last checked: Nov 20, 2026Latest source record: Sep 9, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Sep 9, 2022
Approved
Time to decision
91 days
Received Jun 10, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950005-S084
- Device name
- CELSIUS
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Jun 10, 2022
- Decided
- Sep 9, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P950005
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for software and hardware modifications for the nGEN Generator (compatible with the THERMOCOOL, NAVISTAR, and CELSIUS catheters).
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.